Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,851 | -2,541 | -602 | -887 | N/A |
| Depreciation Amortization | 44 | 10 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 972 | 170 | 132 | 6 | N/A |
| Other Working Capital | 3,031 | 75 | 186 | 33 | N/A |
| Other Operating Activity | 179 | -76 | -82 | 79 | 0 |
| Operating Cash Flow | $-4,625 | $-2,361 | $-367 | $-770 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -114 | -64 | N/A | N/A | N/A |
| Investing Cash Flow | $-114 | $-64 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 208 | 192 | 7 | 334 | N/A |
| Debt Repayment | -190 | -247 | N/A | N/A | N/A |
| Common Stock Issued | 11,329 | 10,305 | N/A | N/A | N/A |
| Other Financing Activity | -509 | -1,865 | 120 | 708 | 0 |
| Financing Cash Flow | $10,837 | $8,385 | $127 | $1,043 | $N/A |
| Beginning Cash Position | 6,276 | 303 | 543 | 270 | N/A |
| End Cash Position | 12,375 | 6,262 | 303 | 543 | N/A |
| Net Cash Flow | $6,099 | $5,959 | $-240 | $273 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,625 | -2,361 | -367 | -770 | N/A |
| Capital Expenditure | -114 | -64 | N/A | N/A | N/A |
| Free Cash Flow | -4,739 | -2,426 | -367 | -770 | 0 |